Michael Lodato, PhD, has been awarded a one-year Research Seed Money Grant from the National Ataxia Foundation to investigate how somatic mutations in Purkinje cells contribute to neurodegeneration in Ataxia Telangiectasia.

Scot Wolfe, PhD, is developing a CRISPR-Cas9 strategy to selectively destroy cancer cells driven by focal gene amplification.